chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up following morning with headache, chills and generalized aches.  That night, chills, headache, and diffuse burning sensation on skin.  on 12/25/20 - developed rash on neck, face and upper chest.  Other symptoms improved, but rash continued for a few days.
Fever greater than 103; body aches; chills; extreme fatigue; severe headache; gradually increasing back pain  Back pain increased every day.  About 3 weeks after vaccine shot, he went to doctor. Back pain continued til he was bedridden bc of severe pain. Went to ER March 22. Tests showed cancer in lungs and hip. Died April 10
AE: Patient had not eaten prior to vaccine, started getting dizzy and clammy after receiving vaccine. Tx: no medications, Symptoms improved with crackers and water. outcome: patient improved spontaneously without medication.                        patient  was discharged home.
Very next day after Had fever, headache, body ache for 3 to 4 days, Migraine for month, went to Doc, got medication for it.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications and drug reactions or allergies was reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 injection, lot # L021367, expiry date 05-NOV-2016 (dose, route of administration and anatomical location were not specified). On an unknown date, the administered doses of PNEUMOVAX 23 underwent temperature excursion at 1 Celsius degrees for 2 hours. There was no previous temperature excursion. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Few minutes after patient received the 3 vaccines,he suddenly had a seizure as I may describe as a vasovagal syncope as it was just a simple fainting spells it was accompanied by jerking movements but there was no confusion or loss of consciousness.Patient regained consciousness as soon as he was put inthe examination table.The faiting just lasted roughly 3 seconds.Emergency measures rendered,BP was 107/65,O2 Sats was 99% on air,Temp 97F,HR 86 and Resp.20.Provider examined the patient and he was completely fine however Emergency EMS was activated and patient was taken to the Hospital for further medical attention.
The patient began experiencing headache the evening of receiving vaccine (02/25/2021). She reports awakening the following morning with left upper and lower extremity pain and weakness and was unable to ambulate.  She also reported some slurring of speech.  These symptoms lasted for a few hours and then resolved.  Headache, left-sided pain and weakness and slurring of speech have resolved.
Cellulitis like localized event to area around injection site. TX: Keflex 500mg PO, TID, x 10
Per pt began as intense itching 2 days after w/ progressive redness to site. Seen today by MD - dx'd w/ allergic urticaria redness  decreased to 3" area below deltoid and itching gone.
Angioedema, SkinRash, Rash & UrticariaPruritus Narrative:  Needed IV corticosteroids and antihistamine.
TD 1995 redness in vaccine area, heat, temp about 100 for approx 2 days. No treatment. 1951 or 1952 ID by a Dr contracted by service. Diphtheria only. Temp, chills, fever, unable to stand, very weak, lasted about 24 hours. Booster shot 1 month later, no reaction. On the booster, Dr only gave enough to take when told of initial reaction. Follow up 02/04/05: Time of administration of the vaccine and lot number not on file.
Developed Guillain Barre Syndrome. Became paralyzed  in November 2021
Evening of 12/5 he felt hot with chills, rhinorrhea and cough.  On 12/6/2015 he had an episode of acute SOB/chest tightness/cough with O2 sat 77%.  Complete recovery in ED with SABA treatment and steroid.  No history of asthma.
patient has swelling  right underneath injection site. Patient was feeling nauseous for 2 days. Patient has fatigue and loss of appetite. patient is feeling better now with just fatigue. suggested contacting Primary care physician if symptoms worsens
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: ER8732), in left arm, on 14Apr2021 as dose 2, single (Lot number: EW0161), in left arm and on 17Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19; COVID 19 Treatment included PAXLOVID from 26Jul2022 to 30Jul2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 09:00 (Lot number: 3014JRA) at the age of 75 years as dose 3 (booster), single for Covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ZYRTEC ALLERGY taken for hypersensitivity; ROSUVASTATIN taken for hypercholesterolaemia; AMLODIPINE taken for blood pressure measurement. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, LOT# EL9266., Caller states that after receiving the first two shots of the vaccine, she had no problem), administration date: 17Feb2021, when the patient was 74 years old, for Covid-19 Immunization, reaction(s): "After receiving the first two shots of the vaccine, she had no problem"; Bnt162b2 (DOSE 2, SINGLE, LOT# EN6208., Caller states that after receiving the first two shots of the vaccine, she had no problem), administration date: 10Mar2021, when the patient was 74 years old, for Covid-19 Immunization, reaction(s): "After receiving the first two shots of the vaccine, she had no problem". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 30Sep2021, outcome "recovered" (03Oct2021), described as "her entire arm ached, all down to her fingers. Her arm was "very very sore from Thursday up to Sunday.""; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "unknown", described as "Under her arm, her lymph nodes are swollen"; LYMPH NODE PAIN (non-serious) with onset 02Oct2021, outcome "unknown", described as "lymph nodes under my arm was very, very sore". Additional Information: Reporter stated that after receiving the first two shots of the vaccine, she had no problem. The reporter stated that she had a mammogram was scheduled on 04OCT2021 and caller found out on 04OCT2021 that shouldn't have a mammogram after having the Pfizer BioNTech Vaccine for at least 6 weeks. Caller wants to know if the swollen lymph nodes she has could generate other side effects and questioning the location of the nodes. No follow-up attempts are possible. No further information is expected. Follow up (02Oct2021): This is a follow up spontaneous report from a contactable consumer. Updated information was added and narrative updated. Follow-up attempts are completed. No further information is expected. Follow up (04Oct2021): This is a follow up spontaneous report from a contactable consumer. Updated information was added and narrative updated. Follow-up attempts are completed. No further information is expected. Follow-Up (11Oct2021): Follow-up attempts are completed. No further information is expected. Updated information was added and narrative updated. Follow-up attempts are completed. No further information is expected.
Patient husband called and said she is experiencing Muscle fatigue, joint pain and some dizziness.
Patient stated that her right arm got very sore after vaccine administration. She couldn't sleep on her right side, and the arm continued to get more sore (upper arm). About 2-3 weeks ago she went to local Dr. who told her she may have had some rotator cuff involvement. Patient then called Clinic and saw Dr. about a week ago. X-rays were done and Dr. told her she had "frozen shoulder" which he told her was not caused by the vaccine, but might have been triggered by the vaccine. Patient received a shot of cortisone and went to first PT appointment today. States she feels so much better and more encouraged since the therapist told her that they believe they will be able to help her.
LEFT ARM HAS BIG BUMP, RASH, ITCHY, HARD TO TOUCH, TENDER, GETTING WORSE SINCE DAY OF INJECTION.
Itching all over my body. I was giving IM Benadryl ten minutes later.
When I got home from receiving the vaccination, my shoulder felt very sore.  When I removed my shirt, I noticed that the injection site (as indicated by the location of the bandaid) was in an unusual location.  Instead of in my shoulder muscle, the injection site was further back toward the back side of my shoulder joint.   My shoulder pain got worse throughout the day and I continue to experience pain when I lift my arm over my head or when I put weight on it while laying down.  I have trouble sleeping with this pain.
Very weak; Diarrhea; Shakiness; Heart palpitations; Weight loss; Nauseous all the time; Vomits a lot; Stayed in bed all day; High Fever; Shivering; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MOBILITY DECREASED (Stayed in bed all day), ASTHENIA (Very weak), DIARRHOEA (Diarrhea), TREMOR (Shakiness) and PALPITATIONS (Heart palpitations) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 010M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced MOBILITY DECREASED (Stayed in bed all day), PYREXIA (High Fever), CHILLS (Shivering) and MYALGIA (Body aches). On 10-Apr-2021, the patient experienced ASTHENIA (Very weak), DIARRHOEA (Diarrhea), TREMOR (Shakiness), PALPITATIONS (Heart palpitations), WEIGHT DECREASED (Weight loss), NAUSEA (Nauseous all the time) and VOMITING (Vomits a lot). On 13-Mar-2021, MOBILITY DECREASED (Stayed in bed all day), PYREXIA (High Fever), CHILLS (Shivering) and MYALGIA (Body aches) had resolved. At the time of the report, ASTHENIA (Very weak), DIARRHOEA (Diarrhea), TREMOR (Shakiness), PALPITATIONS (Heart palpitations), WEIGHT DECREASED (Weight loss), NAUSEA (Nauseous all the time) and VOMITING (Vomits a lot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, Endoscopy: unknown (normal) normal.         No concomitant medications reported. Patient was Admitted to the ER twice, where ECO was performed and came back normal. The patient went to the primary care provider, lab results were normal.  The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine)  was not applicable.
Patient felt very tired on the day following administration of the vaccine, with subsequent rapid total loss of hearing in the L ear and partial loss of hearing in the R ear.  Hearing loss was preceded by intense tinnitus.  Subsequently patient was seen by physician and audiologist on March  9th, hearing loss was confirmed.  Patient was started on prednisone by physician.
Normal, arm soreness in the beginning. This morning. Skin on hands starting to peel. Has not been in the sun.  No behavioral changes for the patient.
This case was reported by a healthcare professional, via another manufacturer (Merck), and described the occurrence of convulsing in a subject of unspecified age and gender who was vaccinated with Tdap (manufacturer unspecified). On an unspecified date the subject received unspecified dose of Tdap (unknown). The vaccine was reported as "Tdap (unspecified manufacturer)". On 18 August 2011, at an unspecified time after vaccination with "Tdap", the subject experienced "convulsing and rolling around". This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
Joint pain; lower back pain; bowel issues; stomach issues; chills; severe neuropathy attack/both feet were on fire when with proper medication, he has been under control for years; This is a spontaneous report from a contactable consumer. A 57-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date: unknown), via an unspecified route of administration in the left arm on 05Mar2021 at 15:45 at a single dose for COVID-19 immunization. Medical history included gout, neuropathy, high cholesterol and heart disease with 4 heart 'stints' and known allergies to dairy. Concomitant medications included colchicine (COLCHICINE), gabapentin (GABAPENTIN), acetylsalicylic acid (ASPRIN). The patient had no other vaccine in four weeks. The patient previously took and had allergies with Cipro [ciprofloxacin] and Erythromycin. It was reported that 20 hours plus after the shot, on 06Mar2021 at 13:15, the patient experienced the most severe neuropathy attack of his life - both feet were on fire when with proper medication, he has been under control for years. The patient also reported joint pain, lower back pain, bowel and stomach issues and chills on 06Mar2021 at 21:15. The patient had no COVID prior to the vaccination and had not tested post vaccination. No treatment administered for the events. The events had not resolved.   Information on the lot/batch number has been requested.
Fatigue within 10hours, chills and fever at 12 hours, sweats at 14 hours and small but noticeable chest ache. Headache at 20 hours. Chest ache continued. Rapid heart rate with mild exertion, with chest ache increasing and more pronounced after activity overnight.
pt recvd vax then walked to chair & c/o feeling dizzy; skin cold, clammy; BP 70/50, P72, R20 1010AM; p/20 mins dizziness subsided skin still cold; BP stable;
Hours after receiving the first shot of Pfizer, I broke out into full body hives. No trouble breathing, no swelling of the throat, never been allergic to a medication before. Hives got increasingly worse for a few days then plateaued and ultimately last for 8 days.
dose given 15-20 minutes after the 6 hour vial puncture expiration; A spontaneous report was received concerning a 78 Years old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and reported dose given 15-20 minutes after the 6 hour vial puncture expiration (Expired product administered ).  The patient's medical history was not known .Products used are unknown.  On 23 Mar 20201, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) via unknown route for prophylaxis of COVID-19 infection.   On 23-Mar-2021, a patient received the Moderna vaccine 15-20 minutes after the 6 hour vial puncture expiration. It was reported that, the patient was monitored for 15 minutes after the vaccine and no adverse events noted by staff.    Treatment information was unknown.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the event was considered as unknown; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 041L20A)  with no associated AEs
Information has been received concerning a pt who was vaccinated on 07/22/98 with varicella vaccine. On 07/03/00 the pt broke out with chickenpox.  It was noted that the pt had 9-10 scabbed lesions and was afebrile. Unspecified medical attention was sought. Follow up information from an RN reported that on 07/18/00 the pt recovered.
got covid; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (got covid) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced COVID-19 (got covid). At the time of the report, COVID-19 (got covid) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment medications were reported. Patient had had first 2 doses of the vaccine in May and  got COVID in December. Patient was scheduled for the booster on 24-Jan-2022 but the pharmacist said that patient had to wait 6 months after having COVID to get the booster.  Company comment: This case concerns a patient of unknown age and gender with no medical history reported, who experienced the unexpected non serious event of COVID 19. The event occurred approximately 6 months after the second dose of mRNA-1273. As reported, patient had had first 2 doses of the vaccine in May and got COVID in December. Patient was scheduled for the booster in January but the pharmacist told the patient that the patient had to wait 6 months after having COVID to get the booster. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a patient of unknown age and gender with no medical history reported, who experienced the unexpected non serious event of COVID 19. The event occurred approximately 6 months after the second dose of mRNA-1273. As reported, patient had had first 2 doses of the vaccine in May and got COVID in December. Patient was scheduled for the booster in January but the pharmacist told the patient that the patient had to wait 6 months after having COVID to get the booster. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Took oral Typhoid 1 capsule 01/17/04.  Developed hives on face spread to neck and back.  Seen at hospital.  Received IV steroids, pepsid, Benardyl.  Released.
4SEP97 spots on face, no temp, no itching, no gland swelling;
Patient was 9 years old at time of vaccination and had already received 2 Primary shots. He should have received the PFIZER 5- 11 Year Bivalent Booster. Instead, he received the PFIZER Primary 5 - 11.  No signs and symptoms at clinic. Parentsw have been contacted to inform them that their son needs to receive the Pfizer Bivalent after the 2-month waiting period.
I got the flu shot on 10/16/2019. Around 20 hours later I started having a watery diarrhea. On Thursday it started and on Friday it continuous. It got worse on Saturday. The last visit to the toilet happened on Sunday. I visited Clinics and I was examined. I was sent home with a test kit to collect material to be examined. Now, it's Sunday night and I'm doing ok. I'm just wondering if diarrhea was reported from people that took the flu shot. I analyzed what I ate and drunk and was nothing out of normal. Please, let me know.
A few days after receiving the Tetanus vaccine, my left foot and ankle starting paining and I could not walk. Then both feet hurt and I went to an internist, then podiatrists, then back to internist trying to get back to normal. I've had chronic trouble with the left foot and ankle with pain, swelling, weakness, a fall, hospital, physical therapy, ankle foot brace, casts, medications, medical foot boot, crutches. Seems to be resulting in permanent problem. I am currently not recovered as of 12-29-14. I was vaccinated due to a cut from metal appendage at a restaurant on 6-13-13. No other vaccinations were received four weeks prior to the tetanus shot. No previous adverse events following any vaccinations in self or siblings.
Swelling and redness to left deltoid, warm tense erythema, 11cm x 12cm to right deltoid. Per phone call on 4/29/06 at 15:30 PM, pt was better.
Cold flash, lightheaded, heavy chest and throat while driving home from receiving vaccine.  Pulled over and called 911 because I thought I was going to pass out and couldn?t breath normally. I was by myself.  Lasted about 3-5 minutes. I started to feel better while on the phone with 911 dispatcher. I was able to walk to the ambulance. Still felt a little woozy, but could breath fine. My chest got a little heavy while in back of ambulance, but not as severe. Was transported to ER.  Discharged same day Diagnosis- vaccine reaction; syncope near-vasovagal reaction
Fever Blister, lower lip and gum; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old male patient received BNT162b2 (BNT162B2), on 11Apr2022 at 14:30 as dose 4 (booster), single (Lot number: 9943) at the age of 84 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TDAP, on 30Mar2022; PLACID [ETOPOSIDE]; CRESTOR; METOPROLOL. Vaccination history included: Covid-19 vaccine (Dose: 3, Manufacturer: Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose:2, Manufacturer: Unknown, Primary immunization complete), for Covid-19 Immunization; Covid-19 vaccine (Dose:1, Manufacturer: Unknown, Primary immunization complete), for Covid-19 Immunization. The following information was reported: ORAL HERPES (non-serious) with onset 14Apr2022, outcome "not recovered", described as "Fever Blister, lower lip and gum". Therapeutic measures were taken as a result of oral herpes with Zovirax. Other vaccine 4 weeks vaccine was on 30Mar2022, Left arm. No covid prior vaccination and no covid tested post vaccination.
Severe pain that has extended from injection site to chest and shoulder--went to ED for the pain.  Unable to contact employee to get more information.
weakness,malaise,injection site pain and swelling Narrative:  patient c/o flue like s/s following receiving COVID vaccine one day ago. Patient c/o redness at the site of injection. On assessment raised bright pink area on right deltoid noted. Area wormer then surrounding tissue on touch, measuring 5cm by 3 cm. Patient states area is "sore and itchy". Patient c/o generalized weakness/malaise, episode liquid diarrhea, light green yesterday. 4/10 headache stating this AM. Left shoulder pain on ROM, 5/10. VS: 119/87, 83, 98% on RA, 98.8. Patient instructed to rest and hydrate.
hives on both arms 5/18/99 told to take DPH;5/19/99 going away almost completely cleared up;
Swelling/itching/ tingling in arms, legs and top of insteps   some itching chin nose.